Catapult Ventures has backed the Manchester based digital health start-up to fund product trials.
"Healthbox CIC, is really excited to work alongside MyHelp. This new innovative product has huge potential not only to save money to an already overstretched mental health system but will also support people and, as an added bonus, save counsellors’ time."
A group of eight NorthInvest angels has backed the medical technology developer.
"Current treatments for these conditions require frequent hospitalisations for intravenous treatment with high doses of diuretics which is not only inconvenient for patients and associated with a risk of kidney injury but also costly. We offer a gentler, safer solution that can be delivered at home, offering patients better quality of life and reducing hospital admissions and costs to healthcare providers. This round of funding enables Renephra to carry out pilot clinical studies to demonstrate a viable success rate in target patients and to understand factors related to success. This is an essential next step for the company in advancing this much needed and promising technology through to regulatory approvals and making it available to clinicians and patients."